Organogenesis Return On Assets from 2010 to 2024

ORGO Stock  USD 2.75  0.02  0.73%   
Organogenesis Holdings Return On Assets yearly trend continues to be very stable with very little volatility. Return On Assets are likely to grow to 0.01 this year. Return On Assets is a profitability ratio that indicates the percentage of profit Organogenesis Holdings earns in relation to its overall resources. It is calculated by dividing net income by total assets. View All Fundamentals
 
Return On Assets  
First Reported
2010-12-31
Previous Quarter
0.01074942
Current Value
0.0113
Quarterly Volatility
0.12982097
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Organogenesis Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organogenesis main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 2.1 M or Selling General Administrative of 146.1 M, as well as many exotic indicators such as Price To Sales Ratio of 2.26, Dividend Yield of 0.0 or PTB Ratio of 1.83. Organogenesis financial statements analysis is a perfect complement when working with Organogenesis Holdings Valuation or Volatility modules.
  
This module can also supplement Organogenesis Holdings' financial leverage analysis and stock options assessment as well as various Organogenesis Holdings Technical models . Check out the analysis of Organogenesis Holdings Correlation against competitors.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.

Latest Organogenesis Holdings' Return On Assets Growth Pattern

Below is the plot of the Return On Assets of Organogenesis Holdings over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Organogenesis Holdings' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organogenesis Holdings' overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Very volatile
   Return On Assets   
       Timeline  

Organogenesis Return On Assets Regression Statistics

Arithmetic Mean(0.02)
Geometric Mean0.01
Coefficient Of Variation(740.07)
Mean Deviation0.07
Median(0.0007)
Standard Deviation0.13
Sample Variance0.02
Range0.6086
R-Value0.07
Mean Square Error0.02
R-Squared0.01
Significance0.79
Slope0
Total Sum of Squares0.24

Organogenesis Return On Assets History

2024 0.0113
2023 0.0107
2022 0.0346
2021 0.21
2020 0.0585
2019 -0.18
2018 -0.4

About Organogenesis Holdings Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Organogenesis Holdings income statement, its balance sheet, and the statement of cash flows. Organogenesis Holdings investors use historical funamental indicators, such as Organogenesis Holdings's Return On Assets, to determine how well the company is positioned to perform in the future. Although Organogenesis Holdings investors may use each financial statement separately, they are all related. The changes in Organogenesis Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organogenesis Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Organogenesis Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Organogenesis Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Assets 0.01  0.01 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out the analysis of Organogenesis Holdings Correlation against competitors.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Organogenesis Stock analysis

When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.307
Earnings Share
0.04
Revenue Per Share
3.313
Quarterly Revenue Growth
0.022
Return On Assets
0.0201
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.